Abstract

BackgroundLaparoscopic splenectomy (LS) being used after Transjugular intrahepatic portosystemic shunt (TIPS) has not been reported. This report aims to explore the feasibility, safety, and potential efficacy of LS after TIPS hypersplenism secondary to portal hypertension (PHT).MethodsWe retrospectively reviewed a series of six patients who underwent LS after TIPS for hypersplenism secondary to PHT between 2014 and 2020. The perioperative data and patients’ clinical outcomes were recorded.ResultsLS was successfully performed in all patients. Hypersplenism was corrected after LS in all six patients. Postoperative prothrombin time, prothrombin activity, international normalized ratio, and total bilirubin showed a trend toward improvement. The preoperative and 1-month postoperative albumin and activated partial thromboplastin levels showed no significant difference. Plasma ammonia level and thromboelastography indicators were ameliorated in two limited recorded patients. No postoperative complications such as subphrenic abscess, portal vein thrombosis, variceal bleeding, hepatic encephalopathy, and liver failure occurred during the 1-month follow-up period.ConclusionLS following TIPS is feasible, safe, and beneficial for patients with hypersplenism secondary to PHT. The following LS not only corrects the hypersplenism, but also has the potential to improve liver function.

Highlights

  • Laparoscopic splenectomy (LS) being used after Transjugular intrahepatic portosystemic shunt (TIPS) has not been reported

  • There has no consensus been reached on the effect of TIPS in treating hypersplenism

  • All patients were diagnosed with portal hypertension (PHT) and hepatitis B virus-related cirrhosis

Read more

Summary

Introduction

Laparoscopic splenectomy (LS) being used after Transjugular intrahepatic portosystemic shunt (TIPS) has not been reported. This report aims to explore the feasibility, safety, and potential efficacy of LS after TIPS hypersplenism secondary to portal hypertension (PHT). PHT leads to many complications including gastroesophageal varices, ascites, splenomegaly, hypersplenism, coagulation. Transjugular intrahepatic portosystemic shunt (TIPS) is mainly used in recurrent and refractory variceal hemorrhage and refractory ascites secondary to PHT [1]. Sanyal et al reported TIPS had no effect on thrombocytopenia. Massoud and Zein found TIPS may improve thrombocytopenia in liver cirrhotic patients [3]. These previous studies have reached conflicting conclusions. The most life-threatening complications after TIPS include HE, heart failure, and liver failure [4]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call